Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 75 results for "cadila pharma"

Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US
Money Control

Pharma weekly wrap: Pharma stocks had tough week due to GST an...

The news highlights in the sector include first quarter results of Sun Pharma, Aurobindo Pharma, Cipla, Cadila Healthcare among others. The US pricing pressure looks more structural than a temporary event. Money Control, 6 days ago
Top buzzing midcap stocks to trade on June 15 Money Control, 2 months ago

28 images for cadila pharma

Money Control, 1 week ago
Money Control, 2 days ago
Money Control, 1 week ago
Money Control, 1 week ago
Money Control, 1 month ago
Money Control, 3 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago

Zydus Cadila's Q1 consolidated net profit up 15%

Pharma major Zydus Cadila on Thursday reported a rise of 14.7 per cent in its consolidated net profit to Rs 25.27 crore during the first quarter ended June 30.On a consolidated basis, the company's total income from operations was reported at Rs 115.54 crore ...
 Prokerala1 week ago Cadila Healthcare Q1 PAT down 30% as GST hurts domestic business  Business Standard1 week ago Father and son Transform Cadila Health to a world beater  The Financial Chronicle1 week ago
Business Standard

Zydus Cadila gets USFDA nod for migraine drug

Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine. According to the company, the drug with strengths 20mg and ...
 SME Times1 month ago Zydus Cadila gets USFDA nod to market Doxazosin tablets  Business Standard1 month ago Zydus Cadila's anti-diabetic drug gets USFDA marketing nod  Business Standard1 month ago Zydus Cadila gets USFDA nod for generic Hepatitis B drug  Business Standard1 month ago
Money Control

Stocks in the news: Tata Motors, Cadila Health, IRB Infra, Bharti Infratel, Bharat Forge

Tata Motors | Wipro | Narayana Healthcare | Crompton Consumer | Cadila Healthcare | Aurobindo Pharma | Cyient | IRB Infrastructure | Timken India | Bharti Airtel | Bharti Infratel | Monnet Ispat | Raymond | Bharat Forge | Tanla Solutions | RBL Bank and Sobha ...
 Money Control1 month ago Stocks in the news: Aurobindo, Cadila, Bajaj Hind, Amtek Auto, Sterlite Tech, NOCIL  Money Control1 month ago Stocks in the news: RIL, Aurobindo, Tata Motors, Strides, Titan, Amtek Auto, Cadila  Money Control2 months ago
Money Control

HDFC Securities positive on Divis, Cadila; neutral on Sun Pharma

In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on a few of the pharma stocks.
 Money Control2 months ago GST to prolong pain for pharma sector finds HDFC securities  Sify1 month ago

Cadila#39;s new MD Sharvil Patel says his vision is to build research-based pharma company

“We have moved a lot of products from the bench to clinic and we need to make sure that we successfully complete our clinical trials and make sure that these products are ready for the global launches,” Sharvil Patel said.
 Money Control1 month ago

Cadila up 10%, pips Lupin to become 2nd most valued pharma co

Shares of Cadila Healthcare surged nearly 10 per cent today, helping the company overtake Lupin to become the second most valued pharma firm in terms of market valuation.
 DNA2 months ago Cadila Healthcare surpasses Lupin to become 2nd most valuable pharma firm  Business Standard2 months ago

Cadila Healthcare aims to double US business to $1 billion in 3 years

Pharma major to launch 100 new products; Moraiya facility slated to come out of US FDA woes
 Business Standard1 month ago

Cadila poised to join billion-dollar sales club in US by FY20

Cipla, Glenmark Pharma to catch up by FY21-22
 Business Standard1 month ago
Sify

Sensex rises as drugmakers, consumer stocks gain

Indian shares rose on Wednesday, with drugmaker Aurobindo Pharma Ltd up on hopes of higher U.S. sales and consumer staple Hindustan Unilever hitting a record high after its June-quarter profit beat expectations. The benchmark BSE Sensex rose 0.53 percent at ...
 Sify1 month ago Indian shares rise as drugmakers, consumer stocks gain  Sify1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less